Abstract: A vehicle control device and a vehicle driving control method include comparing a vehicle's speed with a predetermined first reference speed when a motion sickness prevention mode is entered based on user-configured information about whether to activate the motion sickness prevention mode during driving of the vehicle, and controlling, based on a result of the comparison with the first reference speed, the vehicle to reduce a change in longitudinal acceleration of the vehicle or reduce a feeling of acceleration or deceleration experience by a passenger in the vehicle in consideration of whether an obstacle is recognized.

Abstract: A vehicle control device and a vehicle driving control method include determining whether a motion sickness prevention mode is entered, based on road condition information and user-configured information about whether to activate the motion sickness prevention mode, during driving of a vehicle, and controlling, when the motion sickness prevention mode is entered, the vehicle based on a torque profile generated to reduce a passenger's feeling of acceleration or deceleration depending on whether the vehicle accelerates or decelerates in a high-speed driving situation where the vehicle's speed exceeds a predetermined first reference speed.

Abstract: The present disclosure relates to a pharmaceutical composition comprising chiral nanozyme and method of preventing or treating proliferative diseases using the same. A first nanozyme and/or a second nanozyme according to embodiments of the present disclosure has a chiral structure, and their enzymatic activity is maximized when circularly polarized light with the same directionality as the first nanozyme and/or the second nanozyme is irradiated.

Abstract: A vehicle control device and a vehicle driving control method includes determining whether a motion sickness prevention mode is entered, based on road condition information and user-configured information about whether to activate the motion sickness prevention mode, while a vehicle is driving, and controlling, in case that the motion sickness prevention mode is entered, the vehicle by varying driving control factors, which includes at least one of longitudinal limit acceleration, a hydraulic braking amount, a regenerative braking amount, a braking distribution ratio, and a shift gear configured for the vehicle, depending on whether the vehicle accelerates or decelerates in a low-speed driving situation where the vehicle's speed is equal to or lower than a predetermined first reference speed.

Abstract: A display device includes a substrate, a circuit layer, an element layer, and a sealing layer. The substrate includes a main area and a sub-area. The main area includes a display area and a non-display area. The non-display area includes a dam area in which one or more dam portions surrounding the display area are arranged, and a junction area surrounding the dam area. The sub-area includes a bending area, a first sub-area, and a second sub-area. The circuit layer includes a power supply line. The power supply line includes a main supply portion disposed in the non-display area, a sub-connection portion extending from the main supply portion to the sub-area, and a branch portion disposed in the junction area and protruding from one side of the sub-connection portion. The branch portion is spaced apart from a bank covering a bending hole of the bending area.

Abstract: A memory device includes a memory array configured as quad-level cell (QLC) memory and a control logic operatively coupled to the memory array. The control logic identifies a first two bits of particular pages of a QLC logical state. The control logic causes memory cells of the memory array to be coarse programmed with a threshold voltage distribution of a multi-level cell (MLC) logical state corresponding to the first two bits. The control logic reads the MLC logical state from the memory cells and a second two bits from a cache buffer to determine the QLC logical state. The control logic causes the memory cells to be further coarse programmed with a QLC threshold voltage distribution corresponding to the QLC logical state.

Abstract: Control logic in a memory device initiates a program operation including a first phase including applying a ramping voltage level to a set of wordlines of a memory device to boost a set of pillar voltages and a second phase including applying a set of programming pulses to a wordline associated with one or more memory cells of the memory device to be programmed to a set of programming levels, wherein each programming level of the set of programming levels is programmed by each programming pulse. During the first phase of the program operation, a first voltage applied to a drain-side select line (SGD) is adjusted from a first SGD voltage level to a second SGD voltage level.

Abstract: Control logic in a memory device, identifies a set of a plurality of memory cells associated with a selected wordline to be programmed to respective programming levels during a program operation and causes a set of a plurality of pillars with which the set of the plurality of memory cells are associated to be boosted to respective pillar voltages corresponding to the respective programming levels.

Abstract: A method of a first communication node may comprise: transmitting, to a second communication node, an initiation signal indicating to initiate a collection procedure of training data for a neural network; transmitting, to the second communication node, an information signal including network parameters of the first communication node; receiving, from the second communication node, the training data in response to the information signal; training the neural network using the training data; determining optimal network parameters using the trained neural network; and performing communication with the second communication node using the optimal network parameters.

Abstract: A method for manufacturing a secondary battery according includes accommodating an electrode assembly, in which electrodes and separators are alternately stacked, in a can type battery case; primarily injecting an electrolyte through an injection hole; applying a pressure to the battery case while performing a formation process in a state in which the injection hole is opened; secondarily injecting the electrolyte through the injection hole after performing the formation process, and closing the injection hole.

Abstract: A system for detecting defects includes a memory configured to store a program of instructions; and a processor configured execute the program of instructions to convert an SEM image into an image layout, determine a search space based on performing first layout matching for the image layout and a design layout, match the image layout and the design layout based on performing the second layout matching in the search space, and output defect information based on detecting defects the matched image layout and the matched design layout. The SEM image is an image obtained based on photographing a semiconductor pattern formed on a semiconductor wafer using the design layout based on using a scanning electron microscope.

Abstract: The present invention is related to a method of preparing an alkoxylated resol-type phenol resin and an alkoxylated resol-type phenol resin. An alkoxylated resol-type phenol resin prepared using the method is capable of obtaining a coating film having excellent corrosion resistance, salt resistance, and color characteristics may be prepared, and a composition including the alkoxylated resol-type phenol resin as a curing agent may be suitably used as an vanish for coating the interior of beverage cans.

Abstract: Disclosed herein is a composition comprising a Prunus persica extract for skin wrinkle reduction, anti-oxidation, skin regeneration, skin whitening, or wound healing. Exhibiting high effects of skin wrinkle reduction antioxidation, skin regeneration, skin whitening, or wound healing, the Prunus persica extract can find various applications in cosmetic products for skin wrinkle reduction, antioxidation, skin regeneration, skin whitening and medicinal topical formulations for wound healing.

Abstract: Disclosed is a composition containing natural extracts for enhancement of innate immunity or antiviral use against influenza virus (PR8) or corona virus, wherein the composition promotes interferon secretion in the innate defense immune system to induce protection from the antiviral infection and thus can be effectively used for antiviral use.

Abstract: The present invention provides a composition containing, as active ingredients, Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa, and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects.

Abstract: A method of preventing surge for a vehicle may include detecting, by a controller, whether tip-out of an accelerator pedal is detected, comparing, by the controller, a difference value, obtained by subtracting an exhaust pressure from an intake pressure in a combustion chamber of an engine, with a predetermined reference value when the tip-out of the accelerator pedal is detected, driving, by the controller, a supercharger disposed at the rear end portion of a turbocharger at a predetermined number of revolutions per minute, which is lower than a normal number of revolutions per minute, when the difference value is greater than the reference value, and opening a bypass valve, which performs opening or closing operation and is disposed in a bypass line that diverges from an upstream point of the supercharger and is connected to a downstream point of the supercharger.

Abstract: A method of preventing surge for a vehicle may include detecting, by a controller, whether tip-out of an accelerator pedal is detected, comparing, by the controller, a difference value, obtained by subtracting an exhaust pressure from an intake pressure in a combustion chamber of an engine, with a predetermined reference value when the tip-out of the accelerator pedal is detected, driving, by the controller, a supercharger disposed at the rear end portion of a turbocharger at a predetermined number of revolutions per minute, which is lower than a normal number of revolutions per minute, when the difference value is greater than the reference value, and opening a bypass valve, which performs opening or closing operation and is disposed in a bypass line that diverges from an upstream point of the supercharger and is connected to a downstream point of the supercharger.

Abstract: A method and system for controlling an EGR valve for a vehicle may include an adjusting step of reducing the amount of air flowing into an engine at operation points of the engine lower than a predetermined value at each of the operation points by a controller; a learning step of maintaining, as a reduction-learning amount, a reduction amount of the amount of air from the predetermined value before a malfunction occurs, by the controller, when a malfunction occurs in the engine due to the reduction in the amount of air; a compensating step of determining a compensating air amount at each of the operation points by applying the reduction amount to the predetermined value by the controller; and an EGR controlling step of controlling an EGR-opening amount to satisfy the compensating air amount for a current operation time after the compensating step.

Abstract: The pharmacokinetics and key technologies of the present invention are summarized in FIG. 1. Particularly, malignant misfolded proteins such as mutant huntingtin and alpha-synuclein are coagulated and grow into oligomeric coagulum ({circle around (1)}, {circle around (2)}, fibrillar coagulum ({circle around (3)}) and eventually inclusion body ({circle around (4)}). Young neurons produce a large amount of Nt-Arg through N-terminal arginylation ({circle around (5)}) of vesicle chaperones such as BiP secreted into the cytoplasm, and then arginylated BiP (R-BiP) is secreted binds to the misfolded proteins ({circle around (6)}). As a ligand, the Nt-Arg of R-BiP binds to the p62 ZZ domain ({circle around (7)}), and the normally inactivated closed form of p62 is changed to an open form, leading to structural activation ({circle around (8)}). As a result, PB1 and LC3-binding domains are exposed.

Abstract: A method for controlling an engine system having a supercharger and a turbocharger includes: an accelerator-pedal-opening-degree determination operation of determining whether an opening degree of an accelerator pedal detected after an engine starts is a first reference value or more; a first coolant temperature determination operation of determining whether, when the opening degree of the accelerator pedal is less than the first reference value, a detected temperature of a coolant is a second reference value or more; a second coolant temperature determination operation of determining whether the temperature of the coolant is the second reference value or more and is within a temperature threshold; and a boosting operation of calculating boosting contribution rates of the supercharger and the turbocharger, respectively, when the determined temperature of the coolant is within the temperature threshold and driving the supercharger and the turbocharger using the calculated boosting contribution rates.